Kindstar Globalgene Technology, Inc. (HK:9960) has released an update.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Kindstar Globalgene Technology, Inc. has updated investors on its recent acquisitions and new contractual arrangements, indicating that two executive directors, Dr. Huang Shiang and Mr. Tu Zanbing, are registered shareholders connected to the deals. The company has received confirmation from the Stock Exchange that these transactions fall under the scope of an IPO Waiver, exempting them from certain listing rules requirements. The announcement underscores the company’s adherence to the initial public offering’s conditions and its ongoing compliance with regulatory frameworks.
For further insights into HK:9960 stock, check out TipRanks’ Stock Analysis page.